Wolverine Trading’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,900
Closed -$225K 4762
2024
Q2
$225K Buy
+9,900
New +$228K ﹤0.01% 3721
2020
Q4
Sell
-8,600
Closed -$344K 4771
2020
Q3
$344K Buy
+8,600
New +$365K ﹤0.01% 3223
2019
Q1
Sell
-7,100
Closed -$212K 4487
2018
Q4
$212K Buy
+7,100
New +$221K ﹤0.01% 3623
2017
Q1
Sell
-12,200
Closed -$239K 4220
2016
Q4
$239K Buy
+12,200
New +$221K ﹤0.01% 3525

Other funds holding ATRC

Wolverine Trading's ATRC Position: Q2 2020 in Review

Wolverine Trading sold out of AtriCure (ATRC) in Q2 2020, closing a stake of 6,533 shares — an estimated $214K sold.

Wolverine Trading first reported a position in ATRC in Q3 2016 and held it in 2 quarters. The position peaked at $214K in Q1 2020. 188 funds tracked by Wall St. Rank hold ATRC as of Q2 2020.

  • Wolverine Trading reported no remaining AtriCure position as of Q2 2020 after selling out during the quarter.
  • Wolverine Trading sold 6,533 AtriCure shares in Q2 2020, an estimated $214K.
  • Wolverine Trading first reported a position in AtriCure in Q3 2016 and held it in 2 quarters.
  • Wolverine Trading's AtriCure position peaked at $214K in Q1 2020.
  • 188 funds tracked by Wall St. Rank held AtriCure as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.